EFFECT OF TOPOISOMERASE POISONING BY ANTITUMOR DRUGS VM-26, FOSTRIECIN AND CAMPTOTHECIN ON DNA-REPAIR REPLICATION BY MAMMALIAN-CELL EXTRACTS

被引:17
作者
FROSINA, G
ROSSI, O
机构
[1] Mutagenesis Laboratoryofthe National Center, Tumors of Environmental Origin, Istituto Nazionale Ricerca sul Cancro, 16132 Genova
关键词
D O I
10.1093/carcin/13.8.1371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A recently developed in vitro excision-repair system was used to investigate the effect of the topoisomerase poisons VM 26, fostriecin and camptothecin on DNA repair replication carried out by Chinese hamster ovary cell extracts. VM 26 and camptothecin partially inhibit topoisomerases II and I respectively, which are present in the repair-competent extracts, but have only slight effects on the repair efficiency. On the contrary, the antitumor drug fostriecin markedly affects repair replication but, in contrast to a previous report, does not seem to have, under the experimental conditions used, any inhibitory effect on topoisomerase II. This lack of correlation between the ability to inhibit DNA topoisomerases and the effect on DNA repair replication suggests that topoisomerases should not play a primary role in mammalian excision repair. The use of cleavable-complex stabilizing poisons to investigate the role of eukaryotic topoisomerases in DNA excision repair is discussed.
引用
收藏
页码:1371 / 1377
页数:7
相关论文
共 42 条
  • [1] EFFECT OF EXOGENOUS DNA FRAGMENTS ON HUMAN CELL EXTRACT-MEDIATED DNA-REPAIR SYNTHESIS
    BIGGERSTAFF, M
    ROBINS, P
    COVERLEY, D
    WOOD, RD
    [J]. MUTATION RESEARCH, 1991, 254 (03): : 217 - 224
  • [2] INHIBITION OF TYPE-II TOPOISOMERASE BY FOSTRIECIN
    BORITZKI, TJ
    WOLFARD, TS
    BESSERER, JA
    JACKSON, RC
    FRY, DW
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (21) : 4063 - 4068
  • [3] NEED FOR DNA TOPOISOMERASE ACTIVITY AS A SWIVEL FOR DNA-REPLICATION FOR TRANSCRIPTION OF RIBOSOMAL-RNA
    BRILL, SJ
    DINARDO, S
    VOELKELMEIMAN, K
    STERNGLANZ, R
    [J]. NATURE, 1987, 326 (6111) : 414 - 416
  • [4] CHEN GL, 1984, J BIOL CHEM, V259, P3560
  • [5] TOPOISOMERASE-TARGETING ANTITUMOR DRUGS
    DARPA, P
    LIU, LF
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) : 163 - 177
  • [6] LACK OF CROSS-RESISTANCE TO FOSTRIECIN IN A HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINE SHOWING TOPOISOMERASE-II-RELATED DRUG-RESISTANCE
    DEJONG, S
    ZIJLSTRA, JG
    MULDER, NH
    DEVRIES, EGE
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) : 461 - 464
  • [7] DEJONG S, 1990, CANCER RES, V50, P304
  • [8] NOVOBIOCIN INHIBITION OF DNA EXCISION REPAIR MAY OCCUR THROUGH EFFECTS ON MITOCHONDRIAL STRUCTURE AND ATP METABOLISM, NOT ON REPAIR TOPOISOMERASES
    DOWNES, CS
    ORD, MJ
    MULLINGER, AM
    COLLINS, ARS
    JOHNSON, RT
    [J]. CARCINOGENESIS, 1985, 6 (09) : 1343 - 1352
  • [9] ACTION OF ETOPOSIDE (VP-16-123) ON HUMAN-CELLS - NO EVIDENCE FOR TOPOISOMERASE-II INVOLVEMENT IN EXCISION REPAIR OF UV-INDUCED DNA DAMAGE, NOR FOR MITOCHONDRIAL HYPERSENSITIVITY IN ATAXIA TELANGIECTASIA
    DOWNES, CS
    MULLINGER, AM
    JOHNSON, RT
    [J]. CARCINOGENESIS, 1987, 8 (11) : 1613 - 1618
  • [10] DIRECT INHIBITION OF UV-INDUCED DNA EXCISION REPAIR IN HUMAN-CELLS BY NOVOBIOCIN, COUMERMYCIN AND NALIDIXIC-ACID
    DRESLER, SL
    ROBINSONHILL, RM
    [J]. CARCINOGENESIS, 1987, 8 (06) : 813 - 817